Screening of GPCR drugs for repurposing in breast cancer
Noor Mazin Abdulkareem(University of Houston), Meghana V. Trivedi(University of Houston), Lisa Trinh(University of Houston), Jun Hyoung Park(Baylor College of Medicine), Reid T. Powell(Texas A&M Health Science Center), Mantasha Tabassum(University of Houston), Michael D. Johnson(Georgetown University), Camille A. Johnson(University of Houston), Richard A. Bond(University of Houston), Mary Sobieski(Texas A&M University), Hala Y. Abdelnasser(University of Houston), S. Yande(University of Houston), Clifford Stephan(Texas A&M Health Science Center), Soumya Chikermane(University of Houston), Nghi D. Nguyen(Texas A&M University), Benny Abraham Kaipparettu(Children's Cancer Center), Alexis Ruiz(University Hospital of Basel), Raksha R. Bhat(University of Houston)
Cited by 19
Related Papers
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|860
Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland
|Nature Medicine|2003|581
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
|Cell Reports|2016|382
MDA-MB-435 cells are derived from M14 Melanoma cells––a loss for breast cancer, but a boon for melanoma research
|Breast Cancer Research and Treatment|2006|374